Searched for
API CLAVULANIC ACID
More macro headwinds on the cards? Tackle them with core principles: 6 pharma stocks with upside potential of up to 28%There was a time when the Indian pharma story in the US was almost entirely about inspection risk. The US FDA would inspect a plant, a warn...- Long-term Investing: Ecosystem with an edge called India; 12 large- mid- and small-cap stocks with upside potential of up to 34%Tactical investing should not be confused with long-term investing. In a world where geopolitical risk, commodity shocks, and uncertainty a...
- These large-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of up to 25%Here’s a thing investors in equity need to keep in mind. A large part of the upmove one might see in the next one or two trading sessions w...
- Possibility and probability favour them in war and peace: 10 large-cap stocks from 2 sectors with upside potential of up to 28%Probability theory is important in the stock market. Reason: Stock prices are a function of many factors and the underlying operating matri...
- Being tactical not an option, but a necessity: Prescription for war and volatility; 7 pharma stocks with upside potential of up to 39%In times of major geopolitical conflicts, there is no point in looking at the day-to-day movement of the Nifty and Sensex. There are some s...
- These large- and mid-cap stocks can give more than 25% return in 1 year, according to analystsHere’s one thing to remember in the market: When there is a strong correction that is led by a change in the fundamentals of a sector, it i...
- Pharma stocks: Time to change the prescription? 13 pharma stocks with an upside potential of up to 39%Close to three decades back, when Indian pharma firms began to move into the US market, they faced many challenges. And the fact is that th...
- Centre draws a price line to curb cheap pharma importsIndia has set a minimum import price for essential drug ingredients. The aim is to protect domestic manufacturers from aggressive pricing b...
- Indian or MNC pharma companies? There are reasons to look at both: 5 pharma stocks with upside potential of up to 38%Around two decades ago, as Indian pharma firms first began to move into the US market, they faced many challenges, the biggest of which was...
- These large-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of more than 25%The markets have a big element of probability. The way things have panned out in the past few weeks, it is very likely that the bulls will ...
- Cough in India often treated with unnecessary antibiotics: StudyA recent study in India reveals that cough diagnosis lacks proper classification, leading to antibiotic overuse. Researchers analyzing pati...
- Pharma sector: Reasons to look at it beyond the tariff exemption. 7 pharma stocks with an upside potential of up to 43%Along with semiconductors, electronics and IT, pharma is another sector exempt from the Trump tariffs. Still, as the broader indices declin...
- Even in a volatile market, these large-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of more than 36%For some time now we have spoken of the need to keep an eye on the currency markets. While there is a clear indication of a slowdown, what ...
- PM Modi to inaugurate Penicillin-G plant in Andhra Pradesh, reviving India's antibiotic productionPrime Minister Narendra Modi is expected to inaugurate a new Penicillin-G plant in Andhra Pradesh, marking the revival of domestic producti...
- India takes tiny steps back from its China dependencyIndia is striving to reduce its dependency on China for pharmaceutical raw materials by promoting domestic production through a Production-...
- India starts making key API clavulanic acidIndia has begun producing clavulanic acid, a key ingredient in the antibiotic Augmentin, reducing its reliance on China for APIs. Mumbai-ba...
- Stock picks of the week: 5 stocks with consistent score improvement and upside potential of up to 34%Given the way indices and broader markets have panned out, it is very likely that we are going to soon see the market hitting new highs. Th...
- India all set to make Penicillin G after three decades on PLI pushIndia stopped producing the two input drugs about three decades ago and since then it has relied on China for their supplies. "As of now, w...
- Centre looking to hike import duty on bulk drugs, in bid to boost local manufacturingThe department of pharmaceuticals (DoP) is mulling the proposal as it pushes to make India self-reliant on APIs. A committee of experts for...
- Local Pharma API companies to gain from Rs 10,000 crore schemeThe incentive — part of a .`10,000-crore production-linked incentive scheme to boost domestic manufacturing of critical bulk drugs and APIs...
Load More
